Sirona Capital

Investor type Micro VC

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$82M
Portfolio companies 9
Rounds per year 0.83
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 6
Key employees 3
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Health Care
  • Therapeutics
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sirona Capital:
Typical Co-investors
Sirona Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sirona Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Philippines
Funds with similar focus located in Philippines:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Fuse Biotherapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$9M15 Nov 2021 Los Angeles, California, United States

Antiva Biosciences

Biotechnology
Health Care
Medical
$31M02 Nov 2021 California, United States

ADARx Pharmaceuticals

Biotechnology
Health Care
Medical
Pharmaceutical
$75M08 Sep 2021 San Diego, California, United States

Antiva Biosciences

Biotechnology
Health Care
Medical
$15M10 Jul 2018 California, United States

Constellation Pharmaceuticals

Biotechnology
Genetics
Medical
Pharmaceutical
$100M09 Apr 2018 Cambridge, Massachusetts, United States

Arvinas

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$55M04 Apr 2018 New Haven, Connecticut, United States

TCR2

Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Therapeutics
$125M21 Mar 2018 Cambridge, Massachusetts, United States

Biopharma
Biotechnology
Health Diagnostics
Medical
Wellness
$282M28 Feb 2018 Maryland, United States

Hookipa Pharma

Biotechnology
Clinical Trials
Therapeutics
$60M11 Dec 2017 Vienna, Austria
News
ADARx Raises $75 Million to Advance Growing Pipeline

– ADARx Pharmaceuticals, Inc. completed a $75m Series B financing.
– The round was co-led by SR One Capital Management and OrbiMed Advisors.
Sirona Capital joined this financing as well as existing investor Lilly Asia Ventures.
– The proceeds from the Series B financing will be used to advance ADARx’s proprietary RNA platform technologies for base editing, inhibition, degradation, and delivery.
– The proceeds will also be used to transition ADARx’s growing pipeline of research phase products into the clinic including initiation of a Phase 1 clinical trial for ADARx’s lead program.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sirona Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: